Lucy Abraham

Lucy Abraham is currently the HTA Value & Evidence Team Lead for Migraine in Global Access & Value at Pfizer, a position held since 2022. Prior to this role, Lucy accumulated extensive experience at Pfizer Ltd, where they served as Director of Health Economics & Outcomes Research and Outcomes Research Manager, among other roles. Lucy began their career as a Researcher at the Imperial College School of Medicine and later contributed to outcomes research as a Research Assistant at Pfizer Ltd. They hold a BSc in Psychology from Bangor University and an MSc in Health Psychology from Middlesex University.